In mice bearing melanomas without functional MLKL-mediated necroptosis signaling, ICI immunotherapy failed to boost activation and cytolytic function of CD8+ tumor-infiltrating T cells (figure 3F–G) and had reduced effects on CD4+ T cell activation (online supplemental figure S4B). This evidence concerns the gene MLKL and neoplasm.